SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$0.64 – $0.77
Volume41,361
Market cap$403M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for SLBT.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for SLBT.
Recent news
Company coverage with links to the original publishers.
Science 37, a direct-to-patient clinical research site, has been recognized as a BioSpace 2027 Best Place to Work. The recognition highlights the company's innovative culture, transparency, and clinical quality achievements, including a 97.9% employee retention rate, FDA No Action Indicated classifications with zero Form 483 observations, and approximately 86% study completion rates across 200+ supported clinical trials.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Sep 24, 2012
$0.307
Sep 28, 2012
recurring
Jun 25, 2012
$0.1941
Jun 29, 2012
recurring
Mar 26, 2012
$0.173
Mar 30, 2012
unknown
Dec 23, 2011
$0.1968
Dec 30, 2011
unknown
Sep 26, 2011
$0.1275
Sep 30, 2011
unknown
Stock splits
Historical share-structure events and their execution dates.